Willow Biosciences Inc. announced that the Board of Directors has appointed Dr. Peter Seufer-Wasserthal as Interim President and Chief Executive Officer, effective July 17, 2022, in connection with Trevor Peters' retirement as President and CEO. Mr. Peters will continue to be a Director of the Company. In addition to the above mentioned changes, Ms. Barbara Munroe, a Director of the Company, has been appointed as Lead Independent Director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 CAD | -5.56% | -10.53% | -15.00% |
1st Jan change | Capi. | |
---|---|---|
-15.00% | 7.91M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.12% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.47% | 8.82B |
- Stock Market
- Equities
- WLLW Stock
- News Willow Biosciences Inc.
- Willow Biosciences Inc. Appoints Dr. Peter Seufer-Wasserthal as Chief Executive Officer